Measurable Residual Disease in Acute Lymphoblastic Leukemia: Techniques and Therapeutic Utility CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY Muffly, L. 2022; 20 (7): 419-421

View details for Web of Science ID 000822648800002